Pacer Advisors Inc. Buys Shares of 163,228 Ingevity Corporation $NGVT

Pacer Advisors Inc. bought a new stake in Ingevity Corporation (NYSE:NGVT) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 163,228 shares of the company’s stock, valued at approximately $9,660,000.

Other institutional investors also recently modified their holdings of the company. Principal Financial Group Inc. raised its stake in shares of Ingevity by 269.9% during the fourth quarter. Principal Financial Group Inc. now owns 652,237 shares of the company’s stock worth $38,599,000 after buying an additional 475,907 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after acquiring an additional 454,579 shares during the last quarter. Simcoe Capital Management LLC grew its holdings in Ingevity by 188.8% during the 2nd quarter. Simcoe Capital Management LLC now owns 624,935 shares of the company’s stock worth $26,928,000 after acquiring an additional 408,508 shares during the period. Boston Partners grew its holdings in Ingevity by 141.6% during the 4th quarter. Boston Partners now owns 620,360 shares of the company’s stock worth $36,719,000 after acquiring an additional 363,584 shares during the period. Finally, Goldman Sachs Group Inc. raised its position in shares of Ingevity by 137.7% during the 4th quarter. Goldman Sachs Group Inc. now owns 424,038 shares of the company’s stock valued at $25,095,000 after acquiring an additional 245,620 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on NGVT. BMO Capital Markets reissued an “outperform” rating and issued a $83.00 price target on shares of Ingevity in a research note on Monday, March 2nd. Jefferies Financial Group reiterated a “buy” rating and issued a $82.00 price objective on shares of Ingevity in a report on Thursday, February 26th. Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a research note on Sunday. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a report on Tuesday, April 21st. Finally, Wells Fargo & Company boosted their target price on Ingevity from $65.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, February 27th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $80.00.

Insider Buying and Selling

In related news, SVP Terrance M. Dyer sold 496 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the completion of the transaction, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This represents a 6.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.88% of the company’s stock.

Ingevity Stock Performance

Shares of NGVT opened at $73.17 on Monday. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42. Ingevity Corporation has a twelve month low of $39.74 and a twelve month high of $79.29. The firm’s 50 day moving average price is $71.50 and its two-hundred day moving average price is $67.91. The firm has a market cap of $2.54 billion, a P/E ratio of -20.61 and a beta of 1.18.

Ingevity (NYSE:NGVT) last released its quarterly earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.31. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The company had revenue of $258.00 million during the quarter, compared to analysts’ expectations of $254.73 million. During the same quarter in the prior year, the company earned $1.01 earnings per share. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, analysts forecast that Ingevity Corporation will post 5.05 EPS for the current fiscal year.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.